Samrat Pharmachem standalone net profit rises 717.65% in the December 2024 quarter
Sales rise 3.23% to Rs 63.66 crore
Net profit of Samrat Pharmachem rose 717.65% to Rs 2.78 crore in the quarter ended December 2024 as against Rs 0.34 crore during the previous quarter ended December 2023. Sales rose 3.23% to Rs 63.66 crore in the quarter ended December 2024 as against Rs 61.67 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales63.6661.67 3 OPM %6.570.18 -PBDT4.080.30 1260 PBT3.910.14 2693 NP2.780.34 718Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content